Google will revise its AdMob policy in 2026 to allow programmatic prescription drug ads in specific international markets, removing its…
Read More »ad policy compliance
Microsoft Ads now evaluates ad components (headlines, descriptions, images) independently, allowing campaigns to run smoothly while addressing minor violations instead…
Read More »
Microsoft Ads has updated its policy review system to evaluate individual ad components (headlines, descriptions, images) separately, reducing disruptions while…
Read More »